We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Chip-Based Mobile Blood Diagnosis Takes Only Minutes

By LabMedica International staff writers
Posted on 22 Oct 2009
Print article
New analysis technology takes just a few minutes, and physicians know immediately whether there are any pathogens in the blood. The improved marker-free technique provides the basis for faster analysis, whether in a hospital or for mobile blood donations.

If a person loses a large amount of blood, the consequences can be critical. That is why adequate quantities of donated blood have to be kept available in hospitals and blood banks. In Egypt, doctors collect blood by traveling to towns and villages and conducting blood donation sessions in a laboratory bus. The problem is that 25% of the samples taken contain pathogens, including HIV, hepatitis, and syphilis. As these diseases can be passed on in transfusions, the contaminated blood cannot be used. Conventional fast tests are not suitable in most cases for mobile use.

In the near future, a rapid and robust analysis technique should help. A few drops of blood could be tested in the bus to check whether it can be used. Only if the result is positive will physicians take a larger quantity from the donor. The basis for this has been provided by research scientists from the Fraunhofer Institute for Biomedical Engineering IBMT (Sankt Ingbert, Germany) under a European Union (EU) project also involving the Egyptian company Vacsera (Giza), Mivitec, GmbH (Munich, Germany), the Institute for Analytical Sciences ISAS (Dortmund, Germany), and the University of Lausitz (Germany). "Our consortium has developed a glass chip which has antibodies on it. Tiny surface oscillations are induced in the chip. If the relevant virus binds with an antibody, the oscillation changes,” explained Dr. Thomas Velten, head of department at the IBMT.

The technique is not new, but the new chip that has been developed offers advantages. Usually there is only one measurement field and a reference field next to it, positioned a just a few millimeters apart. But the temperature there can be different. On the new chip, the measurement and reference fields are divided into narrow strips, which in each case are located right next to each other. As a result, the chip is more resistant to fluctuations in temperature. Moreover, the new chip consists of four analysis squares, which means that the blood can be examined for four different pathogens during each test.

It has also been difficult up until now for laboratory workers to avoid contact with the blood and protect themselves from infections while conducting tests in the bus. The researchers at the IBMT have therefore encapsulated the chip. This makes the blood follow a defined course on the chip, protecting the user.

A first prototype of the measurement device is being presented at the Medica trade fair from November 18-21, 2009, in Düsseldorf, Germany.

Dr. Velten estimates that the device could come onto the market in approximately three years' time.

Related Links:

Fraunhofer Institute for Biomedical Engineering IBMT
Vacsera
Mivitec
Institute for Analytical Sciences ISAS


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.